Long-Term Effectiveness & Safety of Medical Cannabis Administered by Metered-Dose SyqeAir Inhaler скачать в хорошем качестве

Long-Term Effectiveness & Safety of Medical Cannabis Administered by Metered-Dose SyqeAir Inhaler

Syqe’s 2022 clinical study evaluated the long-term safety and effectiveness of the SyqeAir Inhaler for patients with chronic neuropathic pain. Unlike traditional consumption methods, this study was conducted in real-world conditions and followed patients over an extended period to assess both therapeutic outcomes and safety. The results showed that long-term use of the SyqeAir Inhaler led to a consistent reduction in pain intensity, significant improvements in quality of life, and a favorable safety profile with minimal adverse events. Notably, these outcomes were achieved with daily doses of medical cannabis that were significantly lower than those typically required with other administration methods. Listen to this short podcast as we explore the study’s findings and their impact on the future of medical cannabis treatment. Read the full article here: https://journals.lww.com/painrpts/ful... Visit our website: https://www.syqe.com/ In accordance with the approved indications in Protocol 106. Subject to the recommendation of a physician and a license for use in accordance with the requirements of the law. Clinically-validated. This is not a medical recommendation.